首页> 外国专利> CONTINUOUS GLUCOSE MONITORING-DIRECTED ADJUSTMENTS IN BASAL INSULIN RATE AND INSULIN BOLUS DOSING FORMULAS

CONTINUOUS GLUCOSE MONITORING-DIRECTED ADJUSTMENTS IN BASAL INSULIN RATE AND INSULIN BOLUS DOSING FORMULAS

机译:连续葡萄糖监测指示的基础胰岛素剂量和胰岛素输注剂量的调整

摘要

A method for individualized management of diabetes in insulin-dependent patients provides a period of evaluation as the patient adheres to a structured pattern of eating, sleeping, and physical activity. Glucose is monitored with a continuous glucose monitoring system, insulin doses are metered, carbohydrate consumption is quantified, and glucose, carbohydrate, and insulin data are collected and analyzed. Insulin dosage is adjusted in three steps: (1) an insulin dosage is estimated from conventional formulas, (2) adjustments are made according to the patient's clinical specifics, and (3) further insulin dose adjustments are made according to glucose data obtained during the evaluation period. By the end of the evaluation period, substantially normal glucose values are achieved, and quantitative relationships from data are calculated that are then applied to determine insulin dosages for an ensuing period of therapy. By this method, diabetic patients achieve a near normal glycemic profile, and without significant occurrence of hypoglycemic episodes.
机译:当患者坚持饮食,睡眠和身体活动的结构化模式时,用于胰岛素依赖型患者的糖尿病个体化治疗的方法可提供一段评估期。用连续葡萄糖监测系统监测葡萄糖,计量胰岛素剂量,量化碳水化合物消耗,并收集和分析葡萄糖,碳水化合物和胰岛素数据。胰岛素剂量可通过三个步骤进行调整:(1)根据常规公式估算胰岛素剂量;(2)根据患者的临床具体情况进行调整;(3)根据在使用过程中获得的葡萄糖数据进一步调整胰岛素剂量评估期。到评估期结束时,基本达到正常的葡萄糖值,并计算数据的定量关系,然后将其用于确定随后的治疗期的胰岛素剂量。通过这种方法,糖尿病患者达到了接近正常的血糖状况,并且没有明显发生降血糖事件。

著录项

  • 公开/公告号US2009036753A1

    专利类型

  • 公开/公告日2009-02-05

    原文格式PDF

  • 申请/专利权人 ALLEN B. KING;

    申请/专利号US20070831623

  • 发明设计人 ALLEN B. KING;

    申请日2007-07-31

  • 分类号A61B5/00;

  • 国家 US

  • 入库时间 2022-08-21 19:30:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号